Loading the records…
Loading the records…
Senator Booker introduced S5022, a bill to decriminalize and deschedule cannabis, on July 16, 2026. The bill is in early stage, referred to the Committee on Finance, with 16 Democratic cosponsors. This is a procedural step with no immediate market impact, but it signals continued legislative pressure for federal cannabis reform.
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
The introduction of S5022 has no immediate market impact. Cannabis stocks ($TLRY, $CGC, ) may see short-term speculative interest, but the bill's early stage and partisan sponsorship mean any price movement is likely noise. Investors should focus on actual legislative progress, such as committee hearings or markup, before adjusting positions.
On July 16, 2026, Senator Cory Booker (D-NJ) introduced S5022, a bill to decriminalize and deschedule cannabis, provide reinvestment in communities impacted by the War on Drugs, and expunge certain cannabis offenses. The bill was read twice and referred to the Committee on Finance. This is an early-stage procedural action; the bill has not been marked up, passed, or signed into law. The bill has 16 cosponsors, all Democrats, including Senate Majority Leader Schumer and Finance Committee Chair Wyden. The bill's referral to the Finance Committee, rather than Judiciary, suggests a focus on tax and revenue implications of cannabis legalization rather than criminal justice reform.
The money trail: S5022 does not authorize or appropriate any specific funding amount. The bill's primary mechanism is regulatory: removing cannabis from the Controlled Substances Act (descheduling) and eliminating federal criminal penalties for cannabis-related activities. This would not directly allocate government funds but would enable state-legal cannabis businesses to access traditional banking, capital markets, and interstate commerce, potentially generating significant tax revenue. The Congressional Budget Office would need to score the bill's revenue impact if it advances.
Convergence: No related signals or procurement data were provided. This bill stands alone as a legislative proposal with no immediate market-moving catalysts.
Structural winners: US multi-state cannabis operators (MSOs) like Tilray Brands ($TLRY) and Canopy Growth ($CGC) would be primary beneficiaries if the bill advances, as federal descheduling removes the primary legal risk that has constrained their access to banking, capital, and interstate operations. The AdvisorShares Pure US Cannabis ETF provides diversified exposure to the sector. However, the bill is in early stage and faces significant legislative hurdles in a divided Congress.
Timeline: The bill is at the beginning of the legislative process. It must be marked up by the Finance Committee, pass the Senate, pass the House, and be signed by the President. Given the partisan nature of the cosponsors and the current political landscape, passage in the 119th Congress is highly uncertain.
Matched on shared policy language across AI analyses, with ticker & timing weight
A bill to create a safe harbor for insurers engaging in the business of insurance in connection with a cannabis-related legitimate business, and for other purposes.
CLIMB Act
To create protections for financial institutions that provide financial services to State-sanctioned marijuana businesses and service providers for such businesses, and for other purposes.
MORE Act
Executive orders & memoranda affecting the same sectors or companies
This executive order directs the Federal Housing Finance Agency to create pilot programs for automatic cancellation of mortgage insurance when borrowers have sufficient equity, and to expand a title insurance pilot to reduce costs for refinancing. It establishes a task force to promote manufactured housing by standardizing permits and reducing regulatory barriers. It also orders the Departments of Agriculture and Veterans Affairs to reduce interest rates on direct home loans.
This executive order establishes a Women's Health Division within the NIH to coordinate and accelerate research on understudied women's health conditions, and creates a White House Women's Health Task Force to drive policy reforms and translation of research into clinical practice across federal agencies. It directs specific agencies to prioritize research, data collection, and translation into prevention, diagnosis, and treatment, with a focus on all life stages from infancy through aging.
This memorandum establishes a committee to investigate Federal Reserve Governor Lisa Cook for alleged false statements related to mortgage instruments, with a hearing scheduled and a recommendation on removal. It directs the Attorney General, Counsel to the President, and others to participate, and sets a timeline for findings.
Free — no credit card
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →